当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析 - 现金流量表

康泰医学

(300869)

  

流通市值:26.48亿  总市值:40.34亿
流通股本:2.64亿   总股本:4.02亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金380,642,193.02255,439,255.57126,491,559.89492,702,503.02
  收到的税费返还63,795.9263,795.9263,795.926,879,099.43
  收到其他与经营活动有关的现金12,592,283.8710,956,513.095,410,228.9122,708,744.15
  经营活动现金流入小计393,298,272.81266,459,564.58131,965,584.72522,290,346.6
  购买商品、接受劳务支付的现金160,397,232.2689,555,379.7934,458,004.08187,492,578.21
  支付给职工以及为职工支付的现金141,181,497.4989,838,87644,233,625178,053,039.89
  支付的各项税费12,031,582.898,441,689.964,777,776.2714,623,229.86
  支付其他与经营活动有关的现金72,045,766.2645,183,753.2121,868,904.7119,834,055.32
  经营活动现金流出小计385,656,078.9233,019,698.96105,338,310.05500,002,903.28
  经营活动产生的现金流量净额7,642,193.9133,439,865.6226,627,274.6722,287,443.32
二、投资活动产生的现金流量:
  收回投资收到的现金1,260,000,0001,210,000,000664,822,958.734,027,202,478.33
  取得投资收益收到的现金54,023,844.8850,369,356.1621,661,735.8552,270,604.65
  处置固定资产、无形资产和其他长期资产收回的现金净额0--143,029.2
  收到的其他与投资活动有关的现金1,235,199,665.28882,267,077.41150,000,000-
  投资活动现金流入小计2,549,223,510.162,142,636,433.57836,484,694.584,079,616,112.18
  购建固定资产、无形资产和其他长期资产支付的现金6,796,530.459,104,110.263,915,426.5949,477,794.15
  投资支付的现金1,460,000,0001,390,000,000794,887,959.053,802,349,675.03
  支付其他与投资活动有关的现金1,767,974,116.64532,449,128.32-0
  投资活动现金流出小计3,234,770,647.091,931,553,238.58798,803,385.643,851,827,469.18
  投资活动产生的现金流量净额-685,547,136.93211,083,194.9937,681,308.94227,788,643
三、筹资活动产生的现金流量:
  取得借款收到的现金25,000,00025,000,00025,000,000275,000,000
  收到其他与筹资活动有关的现金0--22,058,194.44
  筹资活动现金流入小计25,000,00025,000,00025,000,000297,058,194.44
  偿还债务支付的现金195,000,000145,000,00015,424,150.37120,000,000
  分配股利、利润或偿付利息支付的现金15,051,131.612,052,285.91,274,594.39112,108,790.19
  支付其他与筹资活动有关的现金1,344,985.9713,425,712.38706,467.961,428,776.25
  筹资活动现金流出小计211,396,117.58160,477,998.2817,405,212.72233,537,566.44
  筹资活动产生的现金流量净额-186,396,117.58-135,477,998.287,594,787.2863,520,628
四、汇率变动对现金及现金等价物的影响-38,352,680.99-27,328,087.9-13,346,067.85-15,181,674.71
五、现金及现金等价物净增加额-902,653,741.5981,716,974.4358,557,303.04298,415,039.61
  加:期初现金及现金等价物余额982,722,811.09982,722,811.09982,722,811.09684,307,771.48
  期末现金及现金等价物余额80,069,069.51,064,439,785.521,041,280,114.13982,722,811.09
补充资料:
  净利润--49,267,983.28--24,423,861.05
  资产减值准备-33,668,249.14-28,148,237.76
  固定资产和投资性房地产折旧-12,327,389.18-23,346,261.61
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-11,054,787.98-21,425,276.04
    投资性房地产折旧-1,272,601.2-1,920,985.57
  无形资产摊销-1,373,723.31-2,372,292.95
  长期待摊费用摊销-10,959.48-23,994.45
  递延收益摊销--389,102.42--721,533
  处置固定资产、无形资产和其他长期资产的损失-84,751.5-166,264.31
  固定资产报废损失-0--
  公允价值变动损失--2,327,222.03--1,773,267.48
  财务费用-34,074,190.28-20,228,674.56
  投资损失--8,367,926.28--16,729,120.38
  递延所得税--1,408,158.88--3,450,196.45
  其中:递延所得税资产减少--1,352,638.71--3,361,859.4
    递延所得税负债增加--55,520.17--88,337.05
  存货的减少--15,910,993.17-14,593,917.37
  经营性应收项目的减少-4,058,970.58--10,461,192.21
  经营性应付项目的增加-24,921,918.01--10,716,107.01
  现金的期末余额-1,064,439,785.52-982,722,811.09
  减:现金的期初余额-982,722,811.09-684,307,771.48
  现金及现金等价物的净增加额-81,716,974.43-298,415,039.61
公告日期2026-10-302026-08-282026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑